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Abstract 
The aim of this study was to assess the predictive value of lipoproteins and apolipoproteins at a young age for the 
development of coronary artery disease at middle and older ages. Because children of coronary artery disease patients 
are at high risk themselves we compared lipoprotein and apolipoprotein levels between the offspring of parents with 
and without coronary artery disease. We selected a group of male patients (n = 90), who had severe coronary 
atherosclerosis at angiography, and a reference group of male controls (n = 62) who had no coronary atherosclero- 
sis at angiography. Lipoprotein and apolipoprotein levels were determined in 115 sons and 73 daughters of the 
patients with severe coronary atherosclerosis. These were compared to levels in 68 sons and 47 daughters of controls. 
Additionally, lipoprotein and apolipoprotein levels were compared between patients and controls as well as between 
their spouses. In sons of patients, lower levels of HDL, cholesterol ( - 0.07 mmol/l, standard error of the mean 
(SEM) 0.03, P ( 0.05) and apolipoprotein A2 (- 5.1 mg/dl (SEM, 1.4), P ( 0.001) were found compared to sons of 
controls. Similar differences were observed in daughters of such patients without, however, achieving statistical 
significance. No significant differences between the groups of offspring were found for total cholesterol, LDL 
cholesterol, HDL and HDL, cholesterol, triglycerides and apolipoproteins A-I and B. Patients had higher levels of 
total (group difference 0.6 mmol/l (SEM, 0.18), P ( 0.001) and LDL cholesterol (0.6 mmol/l (SEM, 0.17) P ( 0.001) 
triglycerides (0.6 mmol/l (SEM, 0.16), P ( 0.001) and apolipoprotein B (21.2 mg/dl (SEM, 5.1), P ( O.OOl), and lower 
HDL cholesterol (0.1 mmol/l (SEM ,0.04), P ( 0.05) than controls. Spouses of patients had higher levels of 
triglycerides (0.23 mmol/l (SEM, O.ll), P ( 0.05). Our findings add to the growing evidence that predictors for 
atherosclerotic disease can be detected relatively early in life. It is concluded that reduced levels of HDL, cholesterol 
and apolipoprotein A2 may be early risk indicators for coronary atherosclerosis later in life. 
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1. Introduction 
Coronary heart disease as well as its risk factors 
tend to aggregate in families [l-4]. Recent 
prospective studies have shown that a parental 
history of myocardial infarction is an independent 
risk factor for coronary artery disease in offspring 
[5,6]. It follows from this that children of patients 
with coronary heart disease are at increased risk 
of developing the disease at middle or older age. 
Early risk factors for the life-long process of 
atherosclerosis may therefore be identified by re- 
lating disease in parents and risk factors in their 
offspring. Atherosclerotic lesions that developed 
early in life have been shown to be related to 
cholesterol levels and other risk factors [7-lo]. 
Although total serum cholesterol evels measured 
in adolescent men have been shown to be associ- 
ated with the occurrence of manifest cardiovascu- 
lar disease later in life [l 11, less is known about 
the role of lipoprotein and apolipoprotein levels 
in early life as risk factors for atherosclerosis later 
in life. The majority of family studies related risk 
factors in offspring to parental (history of) my- 
ocardial infarction and seem to indicate that spe- 
cifically apolipoproteins B and Al are important 
indicators for risk of myocardial infarction later 
in life [12-151. 
In the present study, we examined the associa- 
tion between offspring risk factors and parental 
atherosclerosis, as assessed by angiography. We 
therefore studied lipoprotein and apolipoprotein 
levels in 188 children of male patients who 
suffered from severe clinically manifest and angio- 
graphically proven coronary atherosclerosis which 
were compared to levels measured in 115 children 
of male controls who did not have coronary 
atherosclerosis at diagnostic coronary angiogra- 
pb. 
2. Subjects and methods 
From 1987 to 1992, two groups of male pa- 
tients were selected from the coronary angiogra- 
phy databases of the cardiology departments of 
the Zuiderziekenhuis in Rotterdam (1987- 1991), 
the Academic Hospital Dijkzigt in Rotterdam 
(1988-1989), the Refaja Ziekenhuis in Dordrecht 
(1990-1991), and the Antonius Hospital in 
Nieuwegein (1992), the Netherlands. The index 
group had severe coronary atherosclerosis, 
defined as more than 70% stenosis in at least three 
major coronary vessels at angiography (patients). 
A reference group had no or only minor angio- 
graphic lesions, defined as 20% stenosis or less in 
all coronary vessels (controls). Additional criteria 
for both groups of men were: (1) age between 45 
and 65 years, (2) blood pressure not exceeding 
160/100 mmhg, (3) absence of liver disease, dia- 
betes mellitus, thyroid disease, and renal disease, 
(4) coronary angiography within 2 years preced- 
ing examination, (5) first consultation of a physi- 
cian for cardiac complaints within 5 years 
preceding examination for this study. Eligible sub- 
jects were sent a letter in which they, their chil- 
dren and spouse were invited to participate in the 
study. Spouses of patients and controls were in- 
cluded in the study to enable distinction between 
a paternal-offspring and a maternal-offspring 
origin of offspring group differences in lipid profi- 
les. The average time elapsed since catheterisation 
to the present examination was 12.6 f 6.0 
months (mean f SD.) for patients and 13.6 f 
6.4 months for controls. 
2.1. Measurements 
The patients, spouse, sons and daughters were 
asked to come to the hospital at 09:OO h after 
fasting for at least 12 h. Systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) were 
measured using a random zero sphygmomanome- 
ter (Hawksley). Fasting serum blood samples were 
drawn by antecubital venipuncture for measure- 
ment of triglycerides, total cholesterol, low den- 
sity lipoprotein cholesterol (LDL cholesterol), 
high density lipoprotein cholesterol (HDL choles- 
terol), its subfractions HDL, cholesterol and 
HDL, cholesterol, apolipoprotein Al, apolipo- 
protein A2, and apolipoprotein B. Height and 
weight were measured without shoes and heavy 
clothing. The Quetelet-index was calculated as 
weight (kg) divided by squared height (m’). 
The patients and controls answered a question- 
naire about the number of first degree relatives 
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who had suffered from myocardial infarctions 
and the use of medication at the time of exami- 
nation (medication was taken to the hospital). 
Parents and children answered a questionnaire 
referring to a l-month period prior to the exam- 
ination, with questions on use of medication, ha- 
bitual alcohol intake, coffee intake, and smoking 
habits. In addition, spouses and daughters were 
asked about the use of oral contraceptives, men- 
strual cycle and pregnancies, Sons and daughters 
were also asked about changes in lifestyle (physi- 
cal activity, smoking behaviour, and fat intake) 
since their fathers had first been examined by a 
physician for cardiac complaints. In the first 50 
families selected for this study all members were 
invited for baseline measurements only. In these 
families the response rate was 92%. In the next 
102 families, the sons (80 sons of patients and 
57 sons of controls) were invited to come to the 
hospital on a separate day because of their 
simultaneous involvement in another study for 
which the criteria and conditions were similar to 
those in the present study. The sons as well as 
the daughters from these 102 families underwent 
the same measurements under the same condi- 
tions as the offspring of the first 50 families. The 
protocol of the extended study required sons 
from these 102 families to stay in the hospital 
for 12 h, and the response rate was lower (65%) 
in this group of sons. 
Table 1 
Characteristics of patients, controls and their spouses 
Patients 
(n = 90) 
Controls 
(n = 62) 
2.2. Laboratory analysis 
Serum total cholesterol was measured with 
an automated enzymatic method, using the 
Boehringer Mannheim (FRG) CHOD-PAP re- 
agent kit [16]. HDL and LDL cholesterol were 
measured by the same method after precipitation. 
For HDL cholesterol, the phosphotungstate 
method according to Burstein et al. [I 71 was used 
with a minor modification as described by Grove 
[18]. For LDL cholesterol, precipitation was car- 
ried out with polyvinylsulphate (Boehringer 
Mannheim, FRG). Throughout the entire study 
period the results of both total cholesterol and 
HDL cholesterol were within limits of the quality 
control programme of the WHO Regional Lipid 
Reference Centre (Prague, Czechoslovakia). 
Apolipoproteins Al and B were assayed by an 
automated immunoturbidimetric method (Kone 
Diagnostics, Espoo, Finland). Apolipoprotein A2 
was determined by radial immunodiffusion 
against specific antiserum (Boehringer Mannheim, 
FRG) according to Cheung and Albers, with 
slight modifications [ 191. All automated analyses 
were carried out on the Kone Specific Analyzer 
(Kone Instruments, Espoo, Finland) using frozen 
(- 20°C) serum samples. HDL, and HDL, 
cholesterol subfractions in serum were assayed as 
described by Gidez et al. [20] with slight modifica- 
tions. 
Spouses of patients 
(n = 91) 
Spouses of controls 
(n = 61) 
Age (years) 56.4 + 1.6 52.2 & 8.1** 52.5 + 9.4 49.2 & 1.9+ 
Height (cm) 175.6 + 6.0 178.6 + 7.9* 166.3 + 6.1 166.2 k 6.4 
Weight (kg) 78.5 + 8.7 79.8 + 11.0 72.4 F 12.5 71.4 * 10.3 
Quetelet-index (kg/m2) 25.4 + 2.2 25.0 + 2.9 26.2 + 4.5 25.9 + 3.9 
SBP (mmHg) 127.2 + 12.8 127.5 5 16.9 127.0 & 16.7 125.3 + 14.8 
DBP (mmHg) 84.1 & 11.1 82.1 f 10.3 83.6 k 11.1 81.0 & 8.3 
Current smoking (Y/o) 18.9 21.0 18.7 36.1* 
Alcohol intake (g/day) 13.8 + 13.6 14.1 * 11.4 6.4 k 1.7 6.7 & 8.0 
Coffee drinking (O/b) 98.9 93.5 97.8 98.4 
Values are means rf: SD., unless stated otherwise; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
*P < 0.05; **P < 0.01; ***P < 0.001 for differences between patients and controls and their spouses. 
HDLz and HDL, cholesterol subfractions were 
separated using stepwise precipitation of apolipo- 
protein B containing lipoproteins with heparin/ 
Mn2+ in two steps and HDL, with 
dextran-sulphate. 
2.3. Statistical methods 
Mean values and standard deviations were cal- 
culated for all characteristics of the patients and 
controls, and their spouses, sons and daughters, 
separately. Mean group differences in baseline 
characteristics were tested with the t-test or 
Mann-Whitney U-test when appropriate, and the 
X2-test for proportional data. All further analyses 
were adjusted for age. Adjusted mean values for 
lipoproteins levels in parents and offspring were 
obtained using linear regression analysis with the 
(apo)lipoprotein level as the dependent and a 
group indicator and age as the independent vari- 
ables. Because of the dependency of measure- 
ments between brothers and between sisters 
within families, group differences between lipo- 
protein values in the offspring were analyzed us- 
ing a repeated measures analysis of variance 
where patients and controls were considered the 
sampling units (BMDP, 1990). In this analysis, 
lipoprotein values in sons and daughters were 
considered repeated measures within families. In 
the repeated measures analysis mean lipoprotein 
levels were adjusted for age, as well as for a 
combination of age, height, weight, systolic blood 
pressure, diastolic blood pressure, smoking, alco- 
hol intake and in daughters, the use of oral con- 
traceptives. The associations between 
(apo)lipoprotein levels in family members were 
assessed by linear regression analysis of patients 
and controls, their spouses, and the first sons or 
daughters taking part in the study. 
3. Results 
Table 1 shows the characteristics of the patients 
and the controls, as well as their spouses. Only the 
group differences in smoking in spouses remained 
statistically significant after adjustment for age. 
Table 2 gives the characteristics for sons and 
daughters of patients and controls. After adjust- 
ment for age only the group differences in dias- 
tolic blood pressure in sons remained statistically 
significant. 
In Table 3, the mean (apo)lipoprotein levels are 
given for patients and controls and their spouses. 
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Table 2 
Characteristics of sons and daughters of patients and controls 
Sons of patients Sons of controls Daughters of patients Daughters of controls 
(n = 115) (n = 68) (n = 73) (?I = 47) 
Age (years) 25.5 + 6.4 22.5 k 5.6** 25.4 k 8.3 21.4 + 7.7** 
Height (cm) 180.8 + 9.7 181.3 f 11.3 167.0 + 7.5 167.6 k 9.9 
Weight (kg) 75.8 + 12.9 73.8 * 13.3 63.7 L- 11.5 60.1 + 14.0 
Quetelet-index (kg/m’) 23.0 + 2.9 22.3 k 3.1 22.9 + 4.0 21.2 iy 3.8* 
SBP (mmHg) 122.9 & 13.4 118.2 + 14.5* 113.5 + 14.5 116.0 k 11.2 
DBP (mmHg) 79.4 f 10.1 73.9 + 12.7** 74.3 + 11.0 72.5 + 8.4 
Current smoking (O/O) 33.9 29.4 37.0 19.1* 
Alcohol intake (g/day) 11.6 + 12.9 9.3 + 9.6 4.8 + 6.0 5.6 + 6.4 
Coffee drinking (%) 82.6 73.5 75.3 51.1** 
Post menarche (%) - 92.8 84.1 
Pregnant at examination - 2.9 7.1 
(%I 
Use of oral contraceptives - 43.5 45.2 
(“W 
Values are means & SD., unless stated otherwise; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
*P < 0.05; **P < 0.01; ***P < 0.001 for differences between sons and daughters of patients and controls. 
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Table 3 
Lipoprotein and apolipoprotein levels in patients and controls and their spouses 
239 
Patients Controls Spouses of patients Spouses of controls 
(n = 90) (N = 62) (n = 91) (n = 61) 
TC (mmol/l) 6.9 (0.11) 6.3 (0.14)*** 6.6 (0.2) 6.6 (0.18) 
LDL-C (mmol/l) 5.1 (0.11) 4.5 (0.13)*** 4.6 (0.15) 4.8 (0.19) 
HDL-C (mmol/l) 1.1 (0.03) 1.2 (0.04)* 1.4 (0.03) 1.3 (0.03) 
HDL,-C (mmol/l) 0.2 (0.01) 0.2 (0.02) 0.4 (0.03) 0.3 (0.02) 
HDL,-C (mmolil) 0.9 (0.02) 0.9 (0.02) 1.1 (0.03) 1.0 (0.02) 
TG (mmol/l) 2.09 (0.09) 1.50 (0.12)*** I .48 (0.08) 1.25 (0.06)* 
Apo Al (mg/dl) 133.5 (2.5) 135.6 (3.8) 155.0 (3.5) 145.2 (3.8) 
Apo A2 (mg/dl) 45.3 (0.8) 46.6 (0.8) 47.3 (0.7) 47.1 (0.9) 
APO B (mgidt) 131.4 (3.3) 110.2 (3.7)*** 111.0 (3.6) 106.0 (3.5) 
Values are means @EM), adjusted for age; TC, total cholesterol; LDL-C. low density lipoprotein cholesterol; HDL-C, high density 
lipoprotein cholesterol; TG, triglycerides; Apo, apolipoprotein. 
*P < 0.05; **P < 0.01; ***P < 0.001 for differences between patients and controls and their respective family members. 
As expected, there were considerable differences 
with regard to lipids and apolipoproteins between 
the patients and controls. Further adjustment for 
other risk factors did not materially change these 
results (data not shown). In the spouses the only 
difference was a higher triglyceride level in the 
spouses of patients and a higher apolipoprotein 
Al after adjustment for other risk factors. 
Table 4 shows the mean age adjusted lipo- 
protein and apolipoprotein values for the sons and 
differences between the two groups of sons for 
lipoprotein and apolipoprotein levels, as analyzed 
with repeated measures analysis of variance. Sons 
of patients on average had adverse lipoprotein 
and apolipoprotein levels compared with sons and 
daughters of controls with significantly lower lev- 
els of HDL, cholesterol and of apolipoprotein A2. 
Table 5 shows lipoprotein and apolipoprotein 
levels for daughters of patients and controls with 
lower HDL, cholesterol and apolipoprotein A2 
levels in daughters of patients, but only reached 
borderline statistical significance. An additional 
repeated measures analysis in which all families 
were excluded if either one or both parents and 
one or more offspring had total cholesterol evels 
exceeding 300 mg/dl, yielded similar results. Ex- 
clusion of families in which one of the parents had 
a total cholesterol evel exceeding 300 mg/dl still 
gave similar results with significantly lower levels 
of. HDL, cholesterol and apolipoprotein A2 in 
sons of patients. 
Fig. 1 gives the associations for total cholesterol 
and apolipoprotein Al among family members. 
Statistically significant associations were found for 
total cholesterol except between fathers and 
spouses and sons and daughters. For LDL choles- 
terol and apolipoprotein B similar associations 
were observed. The strongest associations were 
found for apolipoprotein Al. Between fathers and 
mothers associations were observed for HDL, 
cholesterol (b = 0.25, 95% CI 0.12, 0.39) and 
apolipoprotein Al (b = 0.43, 95% CI 0.32, 0.55). 
Much weaker or no associations between family 
members were observed for the other lipoproteins. 
We assessed the effects of possible changes in 
lifestyle, possibly advised to patients, which may 
have been passed on to the children. There were 
no differences between the two groups of sons 
with regard to changes in reported smoking be- 
haviour, alcohol intake and fat intake after their 
fathers had been first examined for cardiac com- 
plaints. However, 39% of daughters of patients 
reported to have diminished their fat intake, as 
opposed to 17% of daughters of controls (Yates 
corrected x2 5.1, P = 0.02). Life-style advise 
given to patients may be assumed to have more 
influence on offspring living at home than offs- 
pring living separately from their parents. There- 
fore, an additional analysis was performed in the 
offspring living separately from their parents, 
which showed lower levels of HDL, cholesterol 
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Table 4 
Differences in lipoprotein and apolipoprotein levels in the sons of patients and controls 
TC (mmol/l) 
LDL-C (mmol/l) 
HDL-C (mmol/l) 
HDL,-C (mmol/l) 
HDL,-C (mmol/l) 
TG (mmol/l) 
Apo Al (mg/dl) 
Apo A2 (mg/dl) 
APO B (mg/dl) 
Apo Al/Ape B 
Sons of patients 
(n = 115) 
5.4 (0.11) 
3.7 (0.11) 
1.2 (0.02) 
0.2 (0.01) 
0.9 (0.02) 
1.16 (0.06) 
126.6 (2.5) 
44.1 (0.6) 
89.4 (2.5) 
1.6 (0.04) 
Sons of controls 
(n = 68) 
5.0 (0.10) 
3.3 (0.10) 
1.2 (0.03) 
0.2 (0.02) 
1.0 (0.02) 
1.13 (0.07) 
123.8 (2.8) 
47.5 (1.3) 
83.9 (2.5) 
1.5 (0.06) 
Adjusted for 
Age 
Age, risk factorsa 
Age 
Age, risk factors 
Age 
Age, risk factors 
Age 
Age, risk factors 
Age 
Age, risk factors 
fw 
Age, risk factors 
Age 
Age, risk factors 
Age 
Age, risk factors 
Age 
Age, risk factors 
Age 
Age, risk factors 
Difference P-value 
0.11 (0.15) 0.46 
0.0005 (0.16) 0.99 
0.14 (0.15) 0.36 
0.09 (0.16) 0.57 
-0.04 (0.05) 0.43 
-0.07 (0.05) 0.12 
0.02 (0.03) 0.35 
0.005 (0.03) 0.86 
-0.07 (0.03) 0.048 
-0.09 (0.04) 0.007 
-0.03 (0.10) 0.78 
-0.11 (0.10) 0.27 
3.1 (4.8) 0.52 
-2.8 (4.5) 0.54 
-5.1 (1.4) 0.0003 
-4.4 (1.3) 0.0007 
2.1 (3.6) 0.57 
-0.6 (3.7) 0.87 
0.07 (0.08) 0.39 
0.007 (0.08) 0.92 
Values are means (SEM), adjusted for age and mean differences (values sons patients - values sons controls) as calculated with 
repeated measures analysis of variance; p-values compare sons of patients with sons of controls; TC, total cholesterol; LDL-C, low 
density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglycerides; Apo, apolipoprotein. 
aAdjusted for risk factors: height, weight, systolic blood pressure, diastolic blood pressure, smoking, alcohol intake. 
(difference - 0.07 mmol/l (SEM, 0.04) P = 
0.07) and apolipoprotein A2 ( - 5.5 mg/dl (SEM, 
0.5), P = 0.0003) in sons of patients. Similar 
results were observed in daughters of patients who 
had lower levels of HDL, cholesterol ( - 0.12 
mmol/l @EM, 0.05), P = 0.02) and apolipo- 
protein A2 (- 4.5 mg/dl (SEM, 1.9) P = 0.02). 
4. Discussion 
In this study, sons of patients with coronary 
atherosclerosis had lower HDL, cholesterol and 
apolipoprotein A2 levels compared to sons of 
controls. Daughters of patients tended to also 
have lower levels of HDL, cholesterol and 
apolipoprotein A2, but these differences reached 
only borderline significance. No differences were 
found for other lipoproteins and apolipoproteins 
measured. 
Before interpreting these findings some method- 
ologic aspects of the study need to be discussed. 
The angiographical selection of patients and con- 
trols enabled us to maximize the atherosclerotic 
contrast between these groups, as reflected in 
differences in lipoprotein and apolipoprotein lev- 
els. An important advantage of studying risk fac- 
tors in offspring in relation to disease in parents is 
that the risk factors are measured well before the 
manifestations of atherosclerosis. A further ad- 
vantage is that although there may be differences 
between the patients and controls with regard to 
lifestyle and medication, important differences, 
particularly with respect to medication, will not 
be present in the offspring. Although a higher 
proportion of daughters of patients reported to 
have changed fat intake since their father’s first 
examination for cardiac complaints, perhaps ex- 
plaining group differences, this was not accompa- 
nied by a change in other aspects of lifestyle, in 
Table 5 
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Differences in lipoprotein and apolipoprotein levels in the daughters of patients and controls 
Daughters of patients Daughters of controls Adjusted for Difference P-value 
(n = 47) (n 5 73) 
TC (mmol/l) 5.6 (0.14) 5.0 (0.15) 
LDL-C (mmol/l) 3.6 (0.14) 3.1 (0.15) 
HDL-C (mmol/l) 1.5 (0.04) 1.5 (0.04) 
HDL,-C (mmol/l) 0.4 (0.03) 0.4 (0.03) 
HDL,-C (mmol/l) 1.1 (0.02) 1.1 (0.03) 
TG (mmol/l) 1.14 (6.0) 1.04 (8.0) 
Apo Al (mg/dl) 159.6 (3.7) 151.6 (4.3) 
Apo A2 (mg/dl) 46.6 (1.0) 48.0 (1.0) 
APO B (mg/dl) 86.9 (2.6) 77.8 (3.6) 
Apo Al/Ape B 1.9 (0.07) 2.1 (0.09) 
Age 0.19 (0.24) 0.43 
Age, risk factors” 0.28 (0.25) 0.27 
Age 0.16 (0.26) 0.55 
Age, risk factors 0.24 (0.25) 0.34 
Age -0.005 (0.06) 0.87 
Age, risk factors - 0.04 (0.05) 0.44 
Age 0.05 (0.04) 0.10 
Age, risk factors 0.06 (0.04) 0.09 
As - 0.05 (0.04) 0.27 
Age, risk factors - 0.07 (0.04) 0.14 
Age 0.09 (0.12) 0.46 
Age, risk factors 0.13 (0.11) 0.24 
Age 10.6 (6.4) 0.10 
Age, risk factors 11.9 (6.5) 0.07 
Age -2.7 (1.6) 0.11 
Age, risk factors -2.1 (1.6) 0.21 
Age 5.7 (5.2) 0.29 
Age, risk factors 8.1 (4.8) 0.09 
Age -0.05 (0.13) 0.73 
Age, risk factors -0.08 (0.12) 0.45 
Values are means (SEM), adjusted for age and mean differences (values daughters patients - values daughters controls) as 
calculated with repeated measures analysis of variance; P-values compare daughters of patients with daughters of controls; TC, total 
cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglycerides; Apo, 
apolipoprotein. 
“Adjusted for risk factors: height, weight, systolic blood pressure, diastolic blood pressure, smoking, alcohol intake, and use of oral 
contraceptives. 
particular smoking. Furthermore, as it is not Our findings are generally in agreement with 
likely that changes to healthier lifestyles affect those in other studies [21] in that the offspring of 
lipoprotein levels unfavourably, such changes, if patients suffering from coronary artery disease 
present, will result in an underestimation of the have less favourable lipid profiles. However, stud- 
true differences. Support for the absence of im- ies have indicated that particularly apolipoprotein 
portant effects of lifestyle changes was found in Al, apolipoprotein B, and their ratio as measured 
the demonstration of the same differences in offs- in offspring of CAD patients are more strongly 
pring living separately from their parents who are related to risk of cardiovascular disease than 
probably less affected by lifestyle advise given to other (apo)lipoproteins [13- 15,221. In the present 
the patients, as the total groups of offspring. A study, apolipoprotein Al was somewhat higher in 
possible explanation for smaller differences be- offspring of patients. In agreement with earlier 
tween the groups of daughters is that the trans- studies were the higher apolipoprotein B levels in 
mission of risk of atherosclerosis or the offspring of patients, although differences were 
transmission of risk factors is more pronounced not statistically significant. In contrast to earlier 
from fathers to sons than from fathers to daugh- studies, we found HDL, cholesterol and apolipo- 
ters. This might have been different if female protein A2 levels to be lower in offspring of 
coronary artery disease patients and female con- patients. Differences in results may be explained 
trols had been sampled. by the fact that in the majority of the earlier 
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Fathers 
1 
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___ a = 245.4 
p = 0.05 (0.06) 
\ 
Tc 
R = 0.35 
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j3 = 0.32 (0.10) 
FE3 
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j3 = 0.43 (0.06) 
Tc 
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/ 
Mothers 
T.c 
R = 0.34 
a = 167.6 
p = 0.39 (0.12) 
2%5 
a z7i.8 
p = 0.57 (0.10) 
Sons %024 a = 157.3 
p = 0.23 (0.13) 
APQM 
R = 0.61 
a = 49.1 
p = 0.55 (0.10) 
Daughters 
Fig. 1. TC, total cholesterol; Apo Al, apolipoprotein Al; R, correlation coefficient; linear regression: a, intercept; /II, regression 
coefficient (standard error of the mean). 
studies, offspring risk factors were studied in rela- An inverse relation between HDL cholesterol 
tion to myocardial infarction in the parents [13- and risk of ischemic heart disease is well estab- 
151, while the results from the present study lished [23-261. HDL cholesterol levels aggregate 
probably pertain more specifically to atherosclero- in families of patients with myocardial infarction 
sis. Another explanation may be that in the [27,28], and HDL cholesterol subfractions and 
present study the offspring were older than in apolipoproteins Al and A2 have been reported to 
other studies [ 13,221. be strongly and independently associated with risk 
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of myocardial infarction [29,30]. Our results are in 
line with these studies and suggest that HDL 
cholesterol, its subfractions and related apolipo- 
proteins play a role in atherogenesis early in life. 
The specific role of HDL subfractions HDL, and 
HDL, in the inverse relation with ischemic heart 
disease still has to be elucidated, although HDL, 
is thought to be the most important factor in this 
respect. In the present study total HDL choles- 
terol levels are somewhat lower in sons of patients 
and not materially different between the two 
groups of daughters, and HDL, cholesterol tends 
to be higher in both the sons and in daughters of 
patients, which is suggestive of a shift from HDL, 
to HDL, cholesterol. 
In summary, we have found lower levels of 
HDL3 cholesterol and apolipoprotein A2 in the 
offspring, particularly sons, of coronary artery 
disease patients. Our findings add to the growing 
evidence that predictors for atherosclerotic disease 
can be detected relatively early in life. The results 
suggest that reduced levels of HDL, cholesterol 
and apolipoprotein A2 may be early risk indica- 
tors for coronary atherosclerosis later in life. 
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